论文部分内容阅读
目的观察芬舒雅（Ｆａｎｃｉａ）吸入治疗改善微循环障碍的即刻效应及协同效应。方法６０例心脑血管疾病患者进行治疗前后甲襞微循环对比检测与分组比较，用田牛加权积分法评定。结果１治疗后微循环各项积分值改善迅速、显著，尤以血流速度、血管充盈度及毛细血管管径改善更显著（均Ｐ<０.００１～０.０１）；２芬舒雅单独治疗组（２２例）与芬舒雅联合治疗组（３８例）、高血压组（１１例）与高血压合并冠心病组（１４例）及心脑血管病组（４２例）与非心脑血管病组（１８例）组间比较，疗效无显著差异（均Ｐ＞０．０５）。结论芬舒雅改善微循环疗效确切，即刻效应明显，其作用无特异性，与其他增强心血管功能药物有协同效应，可作为防治心脑血管病的药物及非心脑血管疾病的辅助治疗药物。
Objective To observe the immediate and synergistic effects of inhalation therapy with Fancia to improve microcirculatory disturbance. Methods Sixty patients with cardio-cerebral vascular disease were compared before and after treatment with the detection and comparison of the hyperthyroidism microcirculation, and they were evaluated by the weighted integral method. Results 1 The integral value of microcirculation improved quickly and significantly after treatment, especially in blood flow velocity, vascular filling degree and capillary diameter (all P<0.001-0.01); 2 Fusarium alone Treatment group (22 cases) combined with Fenshuya group (38 cases), hypertension group (11 cases) and hypertension combined coronary heart disease group (14 cases), cardiovascular and cerebrovascular disease group (42 cases) and non-cardiac brain There was no significant difference in efficacy between the vascular disease group (18 cases) (P>0.05). Conclusion The efficacy of Fenshuya in improving microcirculation is definite, its immediate effect is obvious, its effect is non-specific, and it has synergistic effects with other drugs that enhance cardiovascular function. It can be used as an adjunctive drug for the treatment of cardiovascular and cerebrovascular diseases and non-cardio-cerebrovascular diseases. .